Dementia neurologist Dr Liz Coulthard describes a news drug called Lecanemab as a "step change" in the treatment of Alzheimer's, after clinical trials showed it can slow the advance of the disease by a quarter.
Report by Blairm.
Like us on Facebook at http://www.facebook.com/itn and follow us on Twitter at http://twitter.com/itn
